MONDAY, May 1, 2023 (HealthDay News) — A mind-reading device seems like science fiction, but researchers say they’re firmly on the path to building one. Using functional MRI (fMRI), a newly developed brain-computer interface can read a person’s thoughts and translate them into full sentences, according to a report publishedContinue Reading

WEDNESDAY, April 26, 2023 (HealthDay News) — An extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder, new clinical trial data show. The new formulation of levodopa, called IPX203, extended the duration of patients’ “on time” — the amount of timeContinue Reading

WEDNESDAY, April 26, 2023 (HealthDay News) – The U.S. Food and Drug Administration on Tuesday approved a new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The medication, toferson (Qalsody), targets a mutation in the SOD1-ALS gene. ALSContinue Reading